NR4A1 and eccrine carcinoma: To investigate the molecular therapeutic target for cutaneous apocrine-eccrine carcinomas, including disease other than that of the vulva, Le et al. performed molecular and immunohistochemical analyses for some cancer genes and hormonal receptors [18].